Panmure Liberum’s Joachim Klement says last week’s Microsoft jolt triggered a contagion effect across trendy assets.
Merck’s outlook for 2026 comes in lower-than-expected as pipeline faces make-or-break year
Merck’s stock falls as the full-year revenue and profit outlooks were below expectations.
